Clinical Trials
3 trialsNCT07431216 2026-03-30
A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression
Starlight Therapeutics Inc.
Phase 1/2 Not yet recruiting
NCT03068910 2025-08-05
CRM008
University of Virginia
Phase EARLY_PHASE1 Recruiting
NCT04723862 2025-08-05
CBS010
University of Virginia
Phase EARLY_PHASE1 Recruiting